In Vivo CRO Market Analysis, Size, Growth, Share, Trend, Forecast 2022 – 2030
In Vivo CRO Market Growth & TrendsThe global in vivo cro market size is expected to reach USD 7.92 billion by 2030, registering a CAGR of 8.2% according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.
In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to the rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.
Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor for USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the
Browse full report with Table of Content (PDF with All Related Graph and Chart)
@: https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market
Rodent-based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice are the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and the focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players
In Vivo CRO Market Segmentation
GrandViewResearchhassegmentedtheglobalinvivoCROmarketbasedonGLPtype, type,indication,andregion:
In Vivo CRO Type Outlook (Revenue, USD Million, 2018 - 2030)
Rodent-based
o Rats
o Mice
o Others
Non-RodentBased
In Vivo CRO GLP Type Outlook (Revenue, USD Million, 2018 - 2030)
Non-GLP
o InHouse
o Outsourcing
GLPToxicology
o InHouse
o Outsourcing
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market/request/rs1
In Vivo CRO Indication Outlook (Revenue, USD Million, 2018 - 2030)
Autoimmune/InflammationConditions
o RheumatoidArthritis
o MultipleSclerosis
o Osteoarthritis
o IrritableBowelSyndrome(IBS)
o Others
PainManagement
o ChronicPain
o AcutePain
Oncology
o BloodCancer
o SolidTumor
o SyngeneicModel
o Patient-derivedXenograft
o Xenograft
o Others
CNSConditions
o Epilepsy
o Parkinson’sDisease
o Huntington’sDisease
o Stroke
o TraumaticBrainInjury
o ALS
o MuscleRegeneration
o Others
Diabetes
Obesity
Others
In Vivo CRO Regional Outlook (Revenue, USD Million, 2018 - 2030)
NorthAmerica
o U.S.
o Canada
Europe
o U.K.
o Germany
o France
o Italy
o Spain
AsiaPacific
o Japan
o China
o India
o Australia
o SouthKorea
LatinAmerica
o Brazil
o Mexico
o Argentina
o Colombia
MiddleEast&Africa
o SouthAfrica
o SaudiArabia
o UAE
List Of Key Players in the In Vivo CRO Market
Covance,Inc.
TheoremClinicalResearch
WuXiAppTec,Inc.
inVentivHealth
Evotec(US),Inc.
CharlesRiverLaboratories
For Requesting a Free Consultation https://www.grandviewresearch.com/request-freeconsultation/3046/rfc
Why Purchase this Report?
A strong research methodology was followed to collect data for the report. The data collected in this way are subjected to several quality checks to provide the best quality.
The report provides a holistic view of the In Vivo CRO Market.
The latest product launches, along with technological changes and developments, are included in the report.
The data analysis in the report will help you In Vivo CRO Market dynamics projected from 2022 - 2030
The Report has a vast data store, so it can accommodate your custom needs as well.
Highlights Points of the Market:
The latest information on how the market is evolving to formulate their sales and marketing strategies. This Market report has been created to provide its readers with up-to-date information and analysis to uncover emerging opportunities for growth.
The market report covers the key challenges, competitive landscape, and demographic analysis that can help companies get insight into the country-specific variations.
The analysts also emphasize on the key trends and the future opportunities that can be explored in the region than can help companies in revenue expansion.
To gain competitive intelligence about leading companies with information about their market share and growth rates.
Know More Related Report:
Biodegradable Plastic Packaging Market Size, Share & Trends Analysis Report By Ingredient, By Source, By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2027
Top And Emerging Biofuels Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025
Bio-based Itaconic Acid Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025